| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |